CDKN2A and in situ carcinoma: Among the 30 genes with the greatest bias in their expression change according to Oncodrive-CIS were CCNE1 and PTEN due to amplifications and CDKN2A, NF1, and NCOA4 due to deletions (Figures S4, S5 and S6).